Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.5 USD | -0.77% | +8.37% | +8.22% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.22% | 13.16B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.45% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+32.41% | 12.55B | |
+24.01% | 12.1B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Transcript : Bio-Techne Corporation Presents at UBS MedTech, Tools and Genomics Summit 2023, Aug-17-2023 10